Cardiosen

Cardiosense — Noninvasive Heart Failure Monitoring

Chicago, United States · Founded 2020 · $15.1M raised

Headquarters
Chicago, Illinois
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$15.1M
Last Round
$15.1M Series ADec 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cardiosense is a venture-backed healthcare technology company developing wearable sensing and AI-driven platforms for noninvasive cardiovascular disease detection and management. Its flagship product, the CardioTag wireless wearable, captures high-fidelity seismocardiographic physiological signals that are analyzed by deep learning algorithms to determine Pulmonary Capillary Wedge Pressure (PCWP) — a critical heart failure indicator — without invasive procedures. The technology received FDA De Novo classification in 2026 and is the first noninvasive tool capable of pressure-guided heart failure management across care settings, from hospitals to home. Cardiosense was co-founded in 2020 and has raised approximately $30M in funding across multiple rounds.

Summary

Cardiosen is an Artificial Intelligence company based in Chicago, United States, founded in 2020. It has raised $15.1M in total across 1 round, most recently a $15.1M Series A round in Dec 2022.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2022
$15.1M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cardiosen on Indexed.vc
<a href="https://indexed.vc/companies/cardiosen"><img src="https://indexed.vc/api/badge/company/cardiosen" alt="Cardiosen on Indexed.vc" width="260" height="76" /></a>